PTC Therapeutics, a global biopharmaceutical company focused on rare disorders, announced that its executives will speak at three upcoming healthcare conferences: Bank of America Securities Health Care Conference on May 12, RBC Capital Markets Global Healthcare Conference on May 20, and Goldman Sachs Annual Global Healthcare Conference on June 9, 2026. These presentations will be webcast live and archived for 30 days on the company’s investor website. This outreach highlights PTC's ongoing efforts to communicate its progress and strategy in developing treatments for rare diseases to investors and stakeholders.
The Low Earth Orbit (LEO) satellite market is projected to expand significantly, reaching a valuation of $74.54 billion by 2035 from $15.77 billion in 2025, with a CAGR of 16.8%. Growth is fueled by rising demand for broadband in underserved areas, c...
During week 21 of 2026 (May 18-22), Sampo Oyj bought back a total of 1,911,568 of its own A-shares across multiple exchanges at a weighted average price of €9.21 per share. This buyback is part of a program authorized by the company's annual general ...
The iShares Core Growth Allocation ETF (AOR), with a 60/40 equity-bond split, returned about 124% over the past decade, significantly underperforming the S&P 500's 261% return. The 40% bond portion has been a drag on returns, especially during period...
WTI crude oil prices fell below $92 amid a stable US-Iran ceasefire that has lasted over seven weeks, easing geopolitical fears and normalizing tanker traffic through the Strait of Hormuz. Brent crude retreated to $95.79, showing neutral to bearish m...
Strategy paused Bitcoin purchases this week to repurchase nearly $1.5 billion in convertible notes, aiming to improve its balance sheet and reduce dilution risks. Michael Saylor indicated that Bitcoin sales before the end of 2026 are "not unlikely" a...
